Gilvetmab: A Novel Immunotherapy in the Fight Against Cancer
- Provider: DVM360
- Location: On-Demand
- Credits: 1
Overview
A one-hour on-demand lecture introducing checkpoint inhibitor immunotherapy in veterinary oncology, focused on gilvetmab and the data behind its conditional licensure.